CTSN PACES (A-Fib) - Clinical Trial

¿Cuál es el Propósito de este estudio?

We are doing this research to learn more about whether taking a blood thinner, along with medications that prevent blood clots, improve outcomes in patients who develop atrial fibrillation (irregular heartbeat) after coronary artery bypass grafting surgery.

¿Cuál es la Condición que se está estudiando?

Atrial Fibrillation (A-Fib)

¿Quién puede participar en el Estudio?

Adults who developed atrial fibrillation after coronary artery bypass grafting surgery.

Grupo etario

Adultos

¿Qué Implica?

If you agree to be in this study, you will:

Be randomly assigned (a fair 50/50 chance) to get the study drug or aspirin for 90 days
Have an in-person study visit at 90 days
Have blood tests
Fill out questionnaires
Have an ECGs (looks at your heart)
Have phone up to 4 phone calls with a member of the study team

If you do not want to be part of the randomized study you may participate in a registry collecting data from your hospitalization for atrial fibrillation.